Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma

By Foss Francine M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1141-1152

Informa Healthcare

Access to resources Recommend Favorite

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

By Dondi Alessandra   Bari Alessia   Pozzi Samantha   Ferri Paola   Sacchi Stefano  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

CD20-positive T-cell Lymphoma with Indolent Clinical Behaviour

By Xiao W-B   Wang Z-M   Wang L-J  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1170-1174

Field House Publishing

Access to resources Recommend Favorite

Romidepsin: In the Treatment of T-Cell Lymphoma

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1469-1480

Adis International

Access to resources Recommend Favorite

Management of cutaneous T-cell lymphoma

By Duhovic Chris   Child Fiona   Wain E Mary  

Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. : 160-164

Royal College Of Physicians

Access to resources Recommend Favorite